title: [Serous central chorioretinopathy and tadalafil: a case report].
abstract: We report a case of central serous chorioretinopathy in a 46-year-old man with no risk factors except for erectile dysfunction agent use: Tadalafil (Cialis(®)). An association between tadalafil and central serous chorioretinopathy could involve phosphodiesterase type 5 inhibitors and be a risk factor of central serous chorioretinopathy.
authors.affiliation: Centre hospitalier d'Avignon, hôpital Henri-Duffaut, 305, rue Raoul-Follereau, 84902 Avignon cedex 9, France. nadeausebastien@hotmail.fr
authors.forename: S
authors.initials: S
authors.lastname: Nadeau
authors.forename: F
authors.initials: F
authors.lastname: Nguyen
authors.forename: S
authors.initials: S
authors.lastname: Guigou
mesh_terms: D002243:Carbolines / Q000009:adverse effects* / Q000627:therapeutic use; D056833:Central Serous Chorioretinopathy / Q000139:chemically induced* / Q000175:diagnosis; D007172:Erectile Dysfunction / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D058986:Phosphodiesterase 5 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000068581:Tadalafil; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D002243:Carbolines; D058986:Phosphodiesterase 5 Inhibitors; D014665:Vasodilator Agents; D000068581:Tadalafil